{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:43:51Z","timestamp":1789386231619,"version":"build-2803163510"},"reference-count":20,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJOG"],"published-print":{"date-parts":[[2005,8]]},"abstract":"<jats:p><jats:bold>Objective\u2003<\/jats:bold> To assess women's acceptability, the efficacy and side effects of sublingual <jats:italic>versus<\/jats:italic> vaginal administration of misoprostol in combination with mifepristone for medical abortion up to 13 weeks of gestation.<\/jats:p><jats:p><jats:bold>Design\u2003<\/jats:bold> Randomised controlled trial.<\/jats:p><jats:p><jats:bold>Setting\u2003<\/jats:bold> Aberdeen Royal Infirmary.<\/jats:p><jats:p><jats:bold>Population\u2003<\/jats:bold> Women undergoing medical abortion under the terms of the 1967 Abortion Act.<\/jats:p><jats:p><jats:bold>Methods\u2003<\/jats:bold> Mifepristone (200 mg) was given orally followed 36\u201348 hours later by misoprostol administration (sublingual: 600 \u03bcg; vaginal: 800 \u03bcg). A second dose of misoprostol 400 \u03bcg was given 3 hours later (sublingually or vaginally). Women between 9 and 13 weeks of gestation received a further (third) dose of misoprostol 400 \u03bcg (sublingually or vaginally), 3 hours later if abortion had not occurred.<\/jats:p><jats:p><jats:bold>Main outcome measures\u2003<\/jats:bold> Women's acceptability, efficacy of the regimen and side effects experienced.<\/jats:p><jats:p><jats:bold>Results\u2003<\/jats:bold> A total of 340 women were recruited (171 sublingual and 169 vaginal). A total of 70% of women in the sublingual group expressed satisfaction with the route of misoprostol administration; 18% answered \u2018Don't know\u2019 while 12% were dissatisfied, compared with 68%, 28% and 4%, respectively, in the vaginal group (<jats:italic>P<\/jats:italic>= 0.02). There was no significant difference in the need for surgical evacuation for women in the sublingual (3\/158, 1.9%) and vaginal groups (4\/156, 2.6%) (<jats:italic>P<\/jats:italic>= 0.70). Women receiving misoprostol sublingually were more likely to experience diarrhoea (<jats:italic>P<\/jats:italic> &lt; 0.01), shivering (<jats:italic>P<\/jats:italic> &lt; 0.01) and unpleasant mouth taste (<jats:italic>P<\/jats:italic> &lt; 0.01).<\/jats:p><jats:p><jats:bold>Conclusions\u2003<\/jats:bold> Sublingual administration of misoprostol is an effective alternative to vaginal administration for medical abortion up to 13 weeks of gestation. The prevalence of prostaglandin\u2010related side effects, however, was higher with this route of administration.<\/jats:p>","DOI":"10.1111\/j.1471-0528.2005.00638.x","type":"journal-article","created":{"date-parts":[[2009,10,7]],"date-time":"2009-10-07T05:18:48Z","timestamp":1254892728000},"page":"1102-1108","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation"],"prefix":"10.1111","volume":"112","author":[{"given":"Haitham","family":"Hamoda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Premila W.","family":"Ashok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian M.M.","family":"Flett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Templeton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,6,7]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-0528.2002.02156.x"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(00)00187-6"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1053\/beog.2001.0272"},{"issue":"1","key":"e_1_2_7_5_2","first-page":"CD002855","article-title":"Medical methods for first trimester abortion","author":"Kulier R","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1521-6934(03)00070-1"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/17.1.92"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199504133321502"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(97)00419-5"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/17.3.654"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(01)00261-X"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2003.07.004"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.4.5883.28"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/17.2.332"},{"issue":"11","key":"e_1_2_7_15_2","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1093\/oxfordjournals.humrep.a138412","article-title":"A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: efficacy and early medical sequelae","volume":"9","author":"Henshaw RC","year":"1994","journal-title":"Hum Reprod"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(89)90094-8"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000115511.14004.19"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0705.2002.00662.x"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2004.02.004"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(01)00205-0"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deg475"}],"container-title":["BJOG: An International Journal of Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-0528.2005.00638.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-0528.2005.00638.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T23:00:26Z","timestamp":1696978826000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-0528.2005.00638.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6,7]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["10.1111\/j.1471-0528.2005.00638.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-0528.2005.00638.x","archive":["Portico"],"relation":{},"ISSN":["1470-0328","1471-0528"],"issn-type":[{"value":"1470-0328","type":"print"},{"value":"1471-0528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6,7]]},"assertion":[{"value":"2005-06-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}